ABUS

ABUS Operating Cash Flow Growth

59.09%TTM

Period ending:

ABUS TTM Cash from Operations YoY %%
ABUS TTM Cash from Operations YoY %10785.29%-94012.86%
2009-06-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

ABUS operating cash flow growth history

Year-over-year operating cash flow growth rate. The available trailing twelve months (ttm) series contains 69 observations from Jun 30, 2009 to Jun 30, 2026.

Arbutus Biopharma Corp Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
59.0886%
41.7161%
38.879%
36.9708%
17.4051%
24.3603%
24.5369%
16.1233%
11.7116%
6.4196%
-143.0592%
-125.5188%
-133.7241%
-186.8421%
47.6456%
39.6686%
40.2204%
46.1063%
-31.2805%
-26.4369%
3.2714%
22.911%
27.554%
33.3882%
5.2572%
-8.3715%
-4.6237%
-22.2377%
-1.341%
-26.2675%
-39.5456%
-15.0993%
-21.984%
20.0492%
15.9785%
10.9988%
-9.797%
-34.8641%
-7.8758%
-35.9833%
1.2188%
-20.1476%
-331.9942%
-1,352.2679%
-83,871.107%
-845.5181%
-84.7758%
-109.6104%
-99.83%
-84.8038%
-120.1339%
521.035%
643.5301%
502.9401%
543.9423%
33.1177%
53.6234%
5.5249%
33.13%
-20.9953%
-69.8808%
4.8478%
-114.6727%
-79.1154%
-3.9488%
-9.7618%
38.2508%
10.7576%
-97.3901%

Compare operating cash flow growth

All ABUS financial metrics · ABUS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.